Marker Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $16.1M | $19.2M | $15.1M | $11.8M | $42.4M | $21.4M | $43.9M | $61.7M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $19.1M | $22.0M | $17.1M | $16.6M | $46.0M | $24.4M | $45.5M | $62.0M |
| Property, Plant & Equipment | — | — | — | $12.3M | $12.3M | $10.4M | $418.0K | $147.7K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $19.1M | $22.0M | $17.1M | $34.4M | $68.1M | $45.6M | $46.4M | $62.1M |
| Liabilities | ||||||||
| Accounts Payable | $793.7K | $1.1M | $961.0K | $1.1M | $5.1M | $2.9M | $993.0K | $1.6M |
| Total Current Liabilities | $2.3M | $3.5M | $3.1M | $7.8M | $12.9M | $6.4M | $2.0M | $2.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $2.3M | $3.5M | $3.1M | $14.8M | $24.1M | $18.3M | $2.3M | $2.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-459.2M | $-447.0M | $-436.3M | $-428.0M | $-398.1M | $-356.2M | $-327.5M | $-306.1M |
| Total Stockholders' Equity | $16.8M | $18.6M | $14.1M | $19.6M | $44.0M | $27.3M | $44.1M | $59.3M |